its absence is informative but not disqualifying, especially when mechanistic and physiological evidence is otherwise robust (Nelson et al., 2015)
GLP-1/exendin-4 facilitates -cell neogenesis in rat and human pancreatic ducts
It is not simply another GLP-1
They are intended for general informational purposes only and do not constitute a medical guarantee or promise of outcome
According to Riccardo Perfetti and colleagues from Cedars-Sinai Medical Center, Division of Endocrinology in Los Angeles, California, continuous infusion of GLP-1 to both young and old rats demonstrated an up-regulation of pancreatic-duodenum homeobox-1 (PDX-1) expression in islets and total pancreas which is essential for pancreogenesis, pancreatic cell differentiation, and maturation
In the general obesity population, cost-effectiveness is highly sensitive to drug price, treatment duration, and reimbursement context, and published models have reached variable conclusions (201203)
